BIRCHBIOMED
  • HOME
  • ABOUT US
  • OUR SCIENCE
  • COMPETITIVE ADVANTAGES
  • OUR TEAM
  • PUBLISHED MEDICAL LINKS
  • IN THE NEWS
  • CONTACT
  • Search
  • Menu Menu

fibrosis

November 18, 2015/by SteveSmiley

Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail
https://birchbiomed.com/wp-content/uploads/2015/11/birchbiomed1.png 0 0 SteveSmiley https://birchbiomed.com/wp-content/uploads/2015/11/birchbiomed1.png SteveSmiley2015-11-18 17:09:512015-11-18 17:09:51fibrosis

Recent Comments

    Archives

    Categories

    • No categories

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About BirchBioMed

    BirchBioMed is a clinical-stage biomedical company focused on the commercialization, clinical evaluation and development of proprietary anti-scarring drugs, autoimmune therapeutics/ therapies and novel strategies for transplantation.

    BirchBioMed Head Office:

    T 866.350.1993
    T 905.833.3414

    E susan.elliott@birchbiomed.com

    In The News

    BirchBioMed welcomes renowned dermatologist to its board of directors

    Birchbiomed announces completion of clinical trial for ground-breaking anti-scarring drug

    UBC Develops Anti-scarring Drug

    CKNW – Sean Leslie Show – Fibrostop, a Drug to Help Burn Victims

    SITE MENU

    • HOME
    • ABOUT US
    • IN THE NEWS
    • OUR SCIENCE
    • OUR TEAM
    • COMPETITIVE ADVANTAGES
    • CONTACT
    ©2021 BirchBioMed. All rights reserved.
    • HOME
    • ABOUT US
    • IN THE NEWS
    • OUR SCIENCE
    • OUR TEAM
    • COMPETITIVE ADVANTAGES
    • CONTACT
    Scroll to top